BMS1P7

Across TCGA pan-cancer cohorts, BMS1P7 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated BMS1P7 data layer compared with 18 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher BMS1P7 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated BMS1P7 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ESCA, OV, and UCEC are the cancer types where BMS1P7 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.043	0.703	<.001	24	view →
OV	DFS	Median	All	0.064	0.541	<.001	18	view →
UCEC	DFS	Median	III,IV	1.000	0.539	.042	10	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

BMS1P7–ESCA (OS)

Open the ESCA breakdown →